The Notch signaling pathway is one of the major pathways mediating direct cellcell contact. A growing body of evidence has suggested that aberrant activations of Notch signaling are associated with the formation and development of human tumors [14] . A variety of mechanisms regulate the Notch signaling pathway to activate the pathway continuously. The nuclear factor kappalightchainenhancer of activated B cells (NF资 B) family is one of the target genes in the Notch signaling pathway. Notch can regulate the expression of NF资 B through proteinprotein interactions and gene transcription regulations [5] . Recent studies have shown that the intracellular domain of the Notch1 receptor (N1IC) directly competes with NF资 B to bind to I资 B, which results in nuclear retention of NF资 B followed by enhanced NF资 B activity [6] . Therefore, the Notch/NF资 B signaling pathway will be a promising target for tumor therapy and play an important role in the screening of specific moleculartargeted drugs.
Celastrol (celastrus orbiculatus thumb) has a pungent and warm property. It is efficient in invigorating blood circulation, promoting the circulation of Qi, detoxifying, and reducing swelling. Celastrol was long ago found to have multiple pharmacologic effects, such as antiinflammatory and antitumor effects. It can inhibit the growth and proliferation of a variety of tumor cells, such as liver, colon, lung, leukemia, brain tumor, and prostate 窑Basic Research 窑 cancer cells [710] . However, only sporadic reports about mechanisms of antitumor activity have been published in recent years [11] . In this study, we used the Notch/NF资 B pathway as a molecular target to study the regulatory effects of different concentrations of Celastrol and the correlation its antileukemia effects.
Celastrol, whose molecular formula is C29H3804 with a molecular weight of 450 and a purity > 95% , was purchased from Sigma Aldrich (USA), dissolved in dimethyl sulfoxide (DMSO) and stored at 20益 . It was diluted to a final concentration in RPMI1640 culture medium immediately before use. The RPMI1640 medium and fetal calf serum was from Gibco (USA). AnnexinV/PI apoptosis kit was purchased from Shenzhen Jinmei BioEngineering Co. Ltd. Mouse antihuman NF资 B/p65 monoclonal antibody and rabbit antihuman Notch1 polyclonal antibody were purchased from the Santa Cruz Biotechnology, Inc. (USA). Fluorescein isothiocyanate (FITC) marked goat antimouse IgG was purchased from Beijing Feiling Technology Co., Ltd. RNA extraction reagent Tzo kit was from Amersham Sweden, AB. The reverse transcriptase polymerase chain reaction (RTPCR) kit was purchased from Fermentas Life Sciences and primers were synthesized by the Shanghai Bioon Infotech Co., Ltd.
Human myeloid leukemia U937 cells were purchased from the Cell Collection Center of Wuhan University. Cells were maintained in RPMI1640 medium containing 10% inactivated fetal bovine serum, 100 u/mL penicillin, and 100 滋 g/mL streptomycin, and were kept in 5% CO 2 at 37益 and saturated humidity. Cells were passaged with medium changes every 12 days. Cells in the logarithmic growth phase whose activity were above 98% were used in these experiments.
An amount of 1 伊 10 5 /mL exponentially growing U937 cells were seeded into each well of 96well plates and Celastrol was added at 0.2516.0 滋 mol/L. Culture media with an equal volume of DMSO was used as a blank control. Three duplicates were created for each concentration with a total volume of 200 滋 L per well. Cells were incubated with 5% CO 2 at 37益 for 1260 h and then 20 滋 L of 5 mg/mL MTT was added into each well. After further incubation at 37益 for 4 h, the supernatant fluid was carefully removed and 150 滋 L of MTT was added to each well. Followed by shaking for 10 min to dissolve any remaining formazan, the optical density ( ) at 492 nm was measured with a BioRad M450 microplate reader. Each experiment was repeated three times and the cellular proliferation inhibition rate (CPIR) was calculated using the following equation: CPIR = (1 mean of experimental group/mean of control group) 伊 100%.
Experiments were carried out according to manufacturer instructions. The samples were divided into experimental groups and a singlelabeled con trol group. U937 cells treated with different concentrations of Celastrol and cells in the blank control group were collected. After rinsing twice with PBS precooled to 4益 , cells were resuspended in 100 滋 L of 1 伊 binding buffer at the density of 1 伊 10 6 /mL. A volume of 5 滋 L of Annexin VFITC and 10 滋 L of PI were added and mixed gently. The cells were incubated in the dark for 15 min at room temperature, then 300 滋 L of the buffers mentioned above were added. Machine detection was performed within 1 h.
A total of 1 伊 10 6 U937 cells in each treatment group were collected, washed in PBS twice, fixed with 70% cold ethanol overnight at 4益, centrifuged, washed again in PBS once, and 20 滋 L RNase A were added, followed by incubating in a 37益 water bath for 30 min. Then 300500 滋 L of propidium iodide (PI) dye was added, mixed, and incubated in the dark for 30 min at 4益 before flow cytometric analysis. The red fluorescence at an excitation wavelength of 488 nm was recorded.
Cells were collected in 1.5 mL of an EP tube. After centrifugation, the supernatant fluid was removed, and 2% glutaraldehyde was added, which were precooled to 4益 to fix for 2 h, then the cells were washed in PBS three times. Fixed in 1% osmium tetroxide for 12 h, gradient dehydrated with ethanol, saturated with 100% acetone epoxy, and embedded with epoxy resin, the cells were made into sections and dyed. Observations were performed with a transmission electron microscope (H7500, Hitachi, Tokyo, Japan).
Total cellular RNA was extracted with a TRIzol kit and complementary DNA (cDNA) was synthesized according to the instructions. Using the first strand cDNA of the cells as a template, PCR was performed. PCR primers were synthesized by the Shanghai Sangon Co., Ltd. The primer pairs of Notch1 were: 5'CAGCGGCTGTACTCGGGCACAG3' (forward) and 5'CAGAAGTGGTCGGAGAACTC3' (reverse), and the amplified fragment was 345 base pairs (bp). The primer pairs of glyceraldehyde 3phosphate dehydrogenase (GAPDH) were: 5'GGGACCTGACTAAcTACCTC3' (forward) and 5'CAGTGATCTCCTTCTCATC3' (reverse), and the amplified fragment was 623 bp. The amplification conditions of PCR were as follows: predenaturation for 2 min at 94益, followed by a total of 35 cycles of denaturation for 30 s at 94益, annealing for 30 s at 58益, and extension for 30s at 72益, then a final extension for 10 min at 72益 , after which the amplification was terminated. After identification by 1.5% agarose gel electrophoresis, the PCR products were photographed under ultraviolet (UV) light and scanning analysis was performed. Notch1/GAPDH were used in the semiquantitative analysis of gene expression levels.
The collected U937 cells treated with different concentrations of Celastrol and cells in the blank control group had 100 滋 L of precooled cell lysis buffer (prepared according to constructions of molecular cloning) added. After 30 min of lysis on ice, total cell protein was extracted and quantified by Lowry assay. Gels and samples were prepared according to conventional methods for protein electrophoresis and the protein was transferred to the membranes. Rabbit antihuman Notch1 monoclonal antibody (1: 1500) was added and the membrane was incubated at 4益 overnight. After rinsing, horseradish peroxidase (HRP)labeled goat antirabbit IgG (1:2000) was added and the membrane was incubated on a shaker at 37益 for 1 h. Finally, electrochemical luminescence reagents were used in Xray imaging and computer software was used to analyze the results. Each group at different concentrations was repeated three times and the mean values represented the results.
Two groups of cells were placed on the cell smear centrifuge. Slides were treated with 3aminopropyltriethoxysilane (APES), then the cell smears were created. After fixation in 4% paraformaldehyde and perforation with 0.1% Tritro X100, a working solution of goat serum was used to block for 1 h. Then 100 滋 L mouse antihuman NF资 B/p65 antibody (primary antibody) diluted in 1% bovine serum albumin (BSA) was added, followed by incubation at 37益 for 1 h. Then the cells were gently washed three times for 10 s each in PBS. As the negative control, 1% BSA instead of the primary antibody was used. A volume of 100 滋 L of FITCconjugated goat antimouse IgG diluted in 1% BSA was added and the slices were incubated at 37益 for 30 min. After washing in PBS, slices were stored in a dark cassette. An inverted fluorescence microscope was used to observe the slices and a digital camera was used to take pictures. An image analysis system was applied to detect the gray value.
The experimental data was measured by 依 s. Comparisons of rates among the groups were performed using test. SPSS version 11.5 was used for statistical analysis.
As seen in Figure 1 As seen from TEM, the cell morphology of the control group was relatively normal, showing typical characteristics of tumor cells with few apoptotic cells. With the increase in concentration of Celastrol, more typical morphologic changes of apoptosis were observed in U937 cell, such as the microvilli on the cell surface disappeared, cell surface blebbing, cytoplasmic density increased, chromosomes condensed and marginalized, nuclei condensed, and apoptotic bodies formed (Figure 2 ). Subsequently, the AnnexinV/PI doublestaining assay (Figure 3 ) quantitatively detected the effect of Celastrol on apoptosis of U937 cells. The results suggested that the proportion of apoptotic U937 cells gradually increased with the increase in the concentration of Celastrol. After being treated with 0.5, 1.0, and 2.0 滋 mol/L of Celastrol for 24 h, apoptotic rates were (9.97 依 0.12)% , (18.02 依 3.50)% , and (32.24 依 3.92)% , respectively. There were significant differences compared with the (2.84 依 1.88)% of the control group ( < 0.01). After being treated with different concentrations of Celastrol for 24 h, the distribution of the cell cycle changed subsequently. The proportion of cells in the G0 /G 1 phase increased gradually with the increase in concentration of Celastrol, while cells in the S phase decreased in a concentrationdependent manner. The effect on cells in G 2 /M phase was not obvious (Table 1, Figure  4) . The results suggested that Celastrol arrested the U937 cell cycle mainly at the G0 /G 1 phase.
To better observe the subcellular localization of NF资 B/p65, we used laser scanning confocal microscopy to detect the distribution. After being treated with 2.0 滋 mol/L of Celastrol for 24 h, the fluorescence intensity of NF资 B/p65 decreased significantly and its subcellular localization also changed. NF资 B/p65 distributed in a circle around the cell surface, and the fluorescence intensity in cytoplasm decreased obviously( Figure 5 ).
There was a high expression of the Notch1 protein in U937 cells. After being treated with 0.58.0 滋 mol/L of Celastrol for 24 h, the level of protein expression decreased significantly in a concentration manner ( < 0.05). To further clarify the effects of Celastrol on the regulation of the Notch1 protein, we detected the content changes of Notch1 mRNA at the level of gene transcription. Similarly, the expression level of Notch1 mRNA decreased in a concentrationdependent manner, which was Figure 4 Effects of Celastrol on cell cycle distribution and early apoptosis for 24 h obviously higher than that of the control group (Figure 6 ).
Many natural agents, especially plants and food ingredients, have been found to have strong antitumor effects in vivo and in vitro. As early as the 1970s, tripterygium wilfordii was reported to have various effects, such as antiinflammatory, analgesic, antioxidant, and antiviral effects, and to play a definite role in inducing tumor cell apoptosis. It was further identified that the characteristics of Celastrol, the active ingredient of tripterygium wilfordii, were different from those of general anticancer drugs. Celastrol could kill tumor cells selectively, while had no obvious damage to normal hematopoietic cells or the heart, liver, kidneys, and so on. As a result, it was considered to be a safe and effective antitumor drug that can be continuously used in the long term [12] . Some sporadic reports have been published about its antitumor mechanisms [11] . This study searched for the possible upstream Notch1/NF资 B p65 signaling pathway, which has been associated with the apoptotic pathway, from a new perspective to further elucidate the effect of Celastrol on growth inhibition and the induction of apoptosis of U937 cells and to clarify its probable mechanisms.
Results showed that Celastrol can inhibit the proliferation of U937 cells and the inhibition was positively correlated with exposure time and concentrations. At the same time, Celastrol had a strong apoptosisinducing effect. After being treated with 0.52.0 滋 mol/L Celastrol for 24 h, the apoptosis rate of U937 cells increased significantly and typical apoptotic morphologic changes were observed. The apoptosisinducing effect of Celastrol may be closely related with its role in cell cycle arrest. Along with increasing concentrations of Celastrol, the proportion of cells in G 0 /G 1 phase increased gradually and the proportion of cells in S phase correspondingly decreased gradually. However, Celastrol had little effect on proportion of cells in G 2 /M phase. Celastrol is speculated to induce apoptosis mainly through blocking U937 cells at the G0/G1 phase, coincident with this report [13] .
In recent years, the Notch1 signaling pathway has been reported to be related to tumorgenesis. Most studies showed that the Notch signaling pathway plays a role in tumor promotion and is highly expressed in a variety of tumor cell lines and primary cells lines derived from diversified malignant tumors, such as hematologic malignancies, endometrial cancer, and colon cancer [1416] . The application of specific blockers of the Notch1 protein could inhibit proliferation and metastasis of the corresponding tumor cells and increase tumor sensitivity to chemotherapeutic drugs [17] . The Notch1 protein is currently believed to exert its activity as an oncoprotein through proteinprotein interactions with factors of tumor necrosis, integrin receptors, and vascular endothelial growth factor (VEGF) [18] . It was not hard to see that the Notch1 signaling pathway was a promising target in cancer therapy.
Therefore, we used the Notch1 gene as a target to observe the regulation of the traditional Chinese medicine preparation Celastrol on the Notch1 protein in U937 cells in this study. The results showed that U937 cells expressed high levels of the Notch1 protein. After treatment with Celastrol, the expression level of both the protein and gene decreased in concentrationdependent manners, which suggests that the effect of Celastrol on proliferationinhibition of U937 cells was closely related to the Notch1 signaling pathway and further confirmed that the inhibition of the Notch1 signaling pathway could inhibit tumor cell proliferation and induce apoptosis. Celastrol is expected to become the next generation of Notch1protein inhibitors.
NF资 B, which was first found in B cells in 1986, is a nuclear protein combined with enhancers of the immune globulin 资 light chain. They are a group of transcription factors composed of Rel family members in homo and heterodimerization. Generally, NF 资 B combined with I资 B is present in the cytoplasm in an inactive form in nonactivated cells. When externally stimulated, I资 B phosphorylation occurs, followed by rapid degradation, and as a result, NF 资 B is released and activated [19] . Results in this experiment showed that, as a strong and effective apoptosisinducing agent, Celastrol could regulate Notch1 at the gene and protein levels, as well as regulate the subcellular localization of transcription factors. After treatment with Celastrol, the fluorescence intensity of NF 资 B in U937 nuclei gradually decreased and was expressed in the highest concentration on the membrane surface to retrieve normal functioning of nucleocytoplasmic shuttling. It suggested that hydrolysis of I资 B decreased after treatment with Celastrol and it combined with NF 资 B and suppressed NF 资 B pathway, leading to reduced [20] confirmed that NF资 B was a target gene of Noahl, and that Notch1 downregulated the expression of NF资 B at the proteinprotein and transcript levels through the recombinant signalbinding protein JK (RBPJK). That gave rise to reduced activity of downstream NF资 B and eventual cell apoptosis. We speculated that the possible mechanism of Celastrol that induces apoptosis in U937 cells may be as follows: Celastrol acts on U937 cells→decreased expression of Notch1→ reduced secretion of NF资 B →apoptosis of leukemia cells. Other studies had also confirmed that NF资 B is an important intermediate pathway in inducing tumor transforming and it may induce apoptosis of tumor cells through regulating the expression of NF资 B [21, 22] . In sum, Celastrol significantly inhibited the proliferation of U937 cells and induced apoptosis. The effects of the Notch1 signaling pathway on the behaviors of tumors suggest that inhibiting its expression could inhibit the growth of tumor cells, promote differentiation or apoptosis of tumor cells, and reduce its invasive activity. This will lay a good foundation toward targeted therapy and drug screening.
